LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Biomarkers of Kidney Disease
- 2nd Edition - November 8, 2016
- Editor: Charles L. Edelstein
- Language: English
- Hardback ISBN:9 7 8 - 0 - 1 2 - 8 0 3 0 1 4 - 1
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 0 3 0 3 5 - 6
Biomarkers of Kidney Disease, Second Edition, focuses on the basic and clinical research of biomarkers in common kidney diseases, detailing the characteristics of an ideal bio… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteBiomarkers of Kidney Disease, Second Edition, focuses on the basic and clinical research of biomarkers in common kidney diseases, detailing the characteristics of an ideal biomarker. The latest techniques for biomarker detection, including metabolomics and proteomics are covered in the book.
This comprehensive book details the latest advances made in the field of biomarker research and development in kidney diseases. The book is an ideal companion for those interested in biomarker research and development, proteomics and metabolomics, kidney diseases, statistical analysis, transplantation, and preeclampsia. New chapters include biomarkers of cardiovascular disease in patients with CKD, biomarkers of Polycystic Kidney Disease, and biomarkers and the role of nanomedicine.
- Explores both the practical and conceptual steps performed in the discovery of biomarkers in kidney disease
- Presents a comprehensive account of newer biomarker discover strategies, such as metabolomics and proteomics, all illustrated by clear examples
- Offers clear translational presentations by the top basic and clinical researchers in each specific renal disease, including AKI, transplantation, cancer, CKD, PKD, diabetic nephropathy, preeclampsia, and glomerular disease
Biomedical researchers, medical fellows, residents, clinicians in nephrology
- Dedication
- List of Contributors
- Preface
- Chapter One: Characteristics of an Ideal Biomarker of Kidney Diseases
- Abstract
- The Discovery of Biomarkers
- Characteristics of an Ideal Biomarker
- Biomarkers in AKI
- Biomarkers in CKD
- Conclusions and Future Directions
- Chapter Two: Statistical Considerations in Analysis and Interpretation of Biomarker Studies
- Abstract
- Introduction
- Planning a Study
- Metrics for Prediction Performance
- Sample-Size Calculations
- Evaluating Incremental Value
- Summary
- Chapter Three: The Role of Metabolomics in the Study of Kidney Diseases and in the Development of Diagnostic Tools
- Summary
- Introduction
- Metabolic Mapping of the Kidney
- Nontargeted and Targeted Metabolomics
- The Sample
- Analytical Technologies
- Metabolic Molecular Marker Discovery and Development
- Metabolomics in Renal Research: Kidney Function, Disease, and Injury Markers
- Metabolomics as a Clinical Diagnostic Tool in Nephrology
- Chapter Four: The Role of Proteomics in the Study of Kidney Diseases and in the Development of Diagnostic Tools
- Abstract
- Introduction
- Nontargeted and Targeted Proteomics
- Proteins and the Kidney
- The Proteomics Sample
- Analytical Technologies
- Proteomics in Renal Research and as a Marker for Kidney Function, Disease, and Injury
- Proteomics as Clinical Diagnostic Tool in Nephrology
- Chapter Five: Cystatin C as a Multifaceted Biomarker in Kidney Disease and Its Role in Defining “Shrunken Pore Syndrome”
- Abstract
- Factors Influencing the Diagnostic Performance of Cystatin C- or Creatinine-Based GFR-Estimating Equations and Causing the Plethora of Equations: The Concepts of “Internal” or “External” Validation
- Optimizing the Use of Cystatin C- and Creatinine-Based GFR-Estimating Equations
- Cystatin C and Creatinine (eGFRcystatin C and eGFRcreatinine) as Markers of End-Stage Renal Disease (ESRD), Hospitalization, Cardiovascular Disease, and Death
- Identification of “Shrunken Pore Syndrome”: Its Influence on Mortality
- Cystatin C as an Indictor of the Circadian Rhythm of GFR
- Cystatin C as an Indicator of “Renal Reserve”
- Chapter Six: Biomarkers in Acute Kidney Injury
- Abstract
- Introduction
- Definition and Classification of AKI
- Serum Creatinine in AKI
- Biology of Biomarkers
- Biomarkers for the Differential Diagnosis of AKI (Table 6.2)
- Biomarkers for the Early Diagnosis of AKI (Table 6.3)
- Biomarkers That Predict Short-Term Outcomes (Table 6.4)
- Biomarkers for Risk Stratification of Patients With Existing AKI (Table 6.5)
- Biomarkers of AKI and Long-Term Outcomes
- Biomarkers of Subclinical AKI (Table 6.6)
- The Effect of Interventions on Biomarkers of AKI (Table 6.7)
- Biomarkers of AKI in the ICU (Table 6.8)
- Urinary Stability Studies for Biomarkers of AKI
- Combinations of AKI Biomarkers
- TIMP2 and IGFBP7 (Table 6.9)
- Conclusions
- Chapter Seven: Biomarkers of Extra-Renal Complications of AKI
- Abstract
- AKI and Inflammation
- Serum Cytokines are Increased in Patients With AKI
- Pulmonary Complications of AKI
- Summary
- Chapter Eight: Biomarkers in Kidney Transplantation
- Abstract
- Biomarkers: An Overview
- Biomarkers of AKI Posttransplantation
- Biomarkers of Acute Rejection
- Biomarkers of Chronic Allograft Nephropathy
- Biomarkers of Polyoma Virus Infection
- Summary
- Chapter Nine: Biomarkers of Renal Cancer
- Abstract
- Renal Cancer
- Cancer Biomarkers—General Concepts
- Renal Cancer Biomarkers
- Conclusions
- Acknowledgments
- Chapter Ten: Proteomics and Advancements in Urinary Biomarkers of Diabetics Kidney Disease
- Abstract
- Introduction
- Urinary Peptides as Biomarkers of Diabetic Kidney Disease
- Future Developments and Applications of Proteomics for Biomarker Discovery
- Chapter Eleven: Biomarkers of Cardiovascular Risk in Chronic Kidney Disease
- Abstract
- Introduction
- The Definition of CKD and the Risk of Cardiovascular Diseases: GFR, Albuminuria, and Proteinuria
- Cardiac Biomarkers in CKD
- Summary
- Chapter Twelve: Diagnostic and Prognostic Biomarkers in Autosomal Dominant Polycystic Kidney Disease
- Abstract
- Genetic Testing for Diagnosis and Prognosis
- Total Kidney Volume
- Renal Blood Flow
- Serum and Urine Biomarkers
- Chapter Thirteen: Biomarkers in Glomerular Disease
- Abstract
- Biomarkers in Glomerular Diseases
- Predictors of Outcome in Glomerular Diseases
- Biomarkers in Lupus Nephritis
- Predictors of Lupus Nephritis Class
- Biomarkers that Predict Renal Lupus Flares
- Membranous Nephropathy
- Focal Segmental Glomerulosclerosis
- Minimal Change Disease
- CD80/B7-1 in Minimal Change and FSGS
- IgA Nephropathy
- Discovery of New Biomarkers Using Proteomics
- Chapter Fourteen: Biomarkers in Preeclampsia
- Abstract
- Definition and Prevalence of the Disease
- Pathophysiology and Mechanisms
- Clinical Manifestations
- Diagnosis
- Biomarkers
- Novel Biomarkers and Future Perspectives
- Conclusions
- Abbreviations
- Index
- No. of pages: 632
- Language: English
- Edition: 2
- Published: November 8, 2016
- Imprint: Academic Press
- Hardback ISBN: 9780128030141
- eBook ISBN: 9780128030356
CE
Charles L. Edelstein
Education and Training: Medical Schools: MD, University Of Stellenbosch, Cape Town, South Africa (1987)
Fellowships: University of Colorado (University Hospital) Program, Nephrology (1997)
Affiliations and expertise
Professor of Medicine and Director of the Renal Hypertension Clinic, University of Colorado Health Sciences Center, Denver, Colorado, USARead Biomarkers of Kidney Disease on ScienceDirect